Literature DB >> 23306065

Ehrlichia chaffeensis replication sites in adult Drosophila melanogaster.

Rishi Drolia1, Tonia Von Ohlen, Stephen K Chapes.   

Abstract

Ehrlichia chaffeensis is a Gram-negative, obligate intracellular bacterium which causes the tick-borne disease human monocytic ehrlichiosis. In vertebrates, E. chaffeensis replicates in monocytes and macrophages. However, no clear cell or tissue tropism has been defined in arthropods. Our group identified two host genes that control E. chaffeensis replication and infection in vivo in Drosophila, Uridine cytidine kinase and separation anxiety. Using the UAS-GAL4 RNAi system, we generated F1 flies (UAS-gene of interestRNAi x tissue-GAL4 flies) that have Uck2 or san silenced in ubiquitous or tissue-specific fashion. When Uck2 or san were suppressed in the hemocytes or in the fat body, E. chaffeensis replicated poorly and caused significantly less severe infections. Silencing of these genes in the eyes, wings, or the salivary glands did not impact fly susceptibility or bacterial replication. Our data suggest that in Drosophila, E. chaffeensis replicates within the hemocytes, the insect homolog of mammalian macrophages, and in the fat body, the liver homolog of mammals.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306065      PMCID: PMC3558598          DOI: 10.1016/j.ijmm.2012.12.002

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  50 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Signaling role of hemocytes in Drosophila JAK/STAT-dependent response to septic injury.

Authors:  Hervé Agaisse; Ulla Maja Petersen; Michael Boutros; Bernard Mathey-Prevot; Norbert Perrimon
Journal:  Dev Cell       Date:  2003-09       Impact factor: 12.270

3.  Development of Ehrlichia canis, causative agent of canine ehrlichiosis, in the tick Rhipicephalus sanguineus and its differentiation from a symbiotic Rickettsia.

Authors:  R D Smith; D M Sells; E H Stephenson; M R Ristic; D L Huxsoll
Journal:  Am J Vet Res       Date:  1976-02       Impact factor: 1.156

4.  Animal model of fatal human monocytotropic ehrlichiosis.

Authors:  E A Sotomayor; V L Popov; H M Feng; D H Walker; J P Olano
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  Natural infection of domestic goats with Ehrlichia chaffeensis.

Authors:  V G Dugan; S E Little; D E Stallknecht; A D Beall
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Persistent Ehrlichia chaffeensis infection occurs in the absence of functional major histocompatibility complex class II genes.

Authors:  Roman Reddy Ganta; Melinda J Wilkerson; Chuanmin Cheng; Aaron M Rokey; Stephen K Chapes
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

7.  Specification of Drosophila hematopoietic lineage by conserved transcription factors.

Authors:  T Lebestky; T Chang; V Hartenstein; U Banerjee
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

8.  Drosophila melanogaster is a genetically tractable model host for Mycobacterium marinum.

Authors:  Marc S Dionne; Nafisa Ghori; David S Schneider
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

Review 9.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

10.  Exploration of host-pathogen interactions using Listeria monocytogenes and Drosophila melanogaster.

Authors:  Bryce E Mansfield; Marc S Dionne; David S Schneider; Nancy E Freitag
Journal:  Cell Microbiol       Date:  2003-12       Impact factor: 3.715

View more
  1 in total

1.  The Impact of RNA Interference in Tick Research.

Authors:  José de la Fuente; Katherine M Kocan
Journal:  Pathogens       Date:  2022-07-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.